News HeadLines – 2012
• Lyon and Grenoble, France, October 1st, 2012. Aguettant and PX'Therapeutics join forces to boost their activities
Press release French version
• Grenoble – France, March 13th, 2012. PX'Therapeutics announces EuroNeut-41 Prophylactic HIV Vaccine clinical trial.
PX'Therapeutics is pleased to announce the launching of a Phase 1 clinical trial of a prophylactic vaccine against HIV entitled: "Phase 1, Randomised, Single-centre, Observerblind Clinical Trial of Safety and Immunogenicity of Nasal-prime and Intramuscular Boost Immunisation With EN41-FPA2 HIV Vaccine in Healthy Female Volunteers"
Press release
Events
We will be attending the following events.
Please do not hesitate
to come and see us at:
• Biopartnering North America - Vancouver, Canada - February 26 – 27th, 2012
• BioEurope Spring – Amsterdam, The Netherlands – March 19th-21st, 2012
• B4B Connection – Bioproduction - Evry, France – February 8-9th
• 7èmes Journées Scientifiques du CLARA – Lyon, France – March 20th-21st
• PEGS 2012 – Boston, USA – April 30th-May 4th
• BIO International Convention – Boston, USA - June 18th-21st
• EuroMeDiag International Convention – Montpellier, France – July 5 - 6th
• BioSpain – Bilbao, Spain – September 19th-21st
• BioPharma Outsourcing – Paris, France – October 24-25th
• BioEurope - Hambourg, Germany - November 12-14th
• BioFit 2012 – Lille, France - 3rd-4th December